YKST02
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for YKST02, covering 2026-02-05 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus Erythematosus [Phase 1]